Comments on: Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211)

Comments on: Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once-Daily Treatment With the Long-Acting Glucagon-Like Peptide 1 Analog Liraglutide (NN2211) http://amaryl-glimepiride.com/2008/04/18/improved-glycemic-control-with-no-weight-increase-in-patients-with-type-2-diabetes-after-once-daily-treatment-with-the-long-acting-glucagon-like-peptide-1-analog-liraglutide-nn2211/ Amaryl (glimepiride) is used together with diet and exercise to treat type 2 diabetes. http://wordpress.org/?v=2.8.4 hourly 1